BRITTANY NYE: Open Payments
NPI 1235600719 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 21 payments from 11 companies in 2025. Trend: 2023 $302 · 2024 $445 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $69 |
| ABBVIE INC. | 3 | $68 |
| Lundbeck LLC | 3 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Astellas Pharma US Inc | 2 | $29 |
| Lilly USA, LLC | 1 | $26 |
| PFIZER INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: REXULTI, FREESTYLE LIBRE, QULIPTA, Kerendia, XIFAXAN, Veozah, MOUNJARO, VRAYLAR.
Industry payments across TX — which companies pay providers there.
